✦ LIBER ✦

Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy

✍ Scribed by Kunimitsu Kanai; Eiji Kikuchi; Takashi Ohigashi; Akira Miyajima; Ken Nakagawa; Jun Nakashima; Mototsugu Oya

Publisher: Springer
Year: 2008
Tongue: English
Weight: 296 KB
Volume: 13
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-008-0779-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with an every-2-week regime

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy

✍ Cora N. Sternberg; Fabio Calabrò; Giorgio Pizzocaro; Luca Marini; Sylvia Schnetz 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Salvage chemotherapy with paclitaxel, if

Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy

✍ Nobuo Shinohara; Toru Harabayashi; Shin Suzuki; Kazuhiro Nagao; Haruo Seki; Masa 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 214 KB

Gemcitabine and docetaxel as second-line

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

✍ Christos Kosmas; Nicolas Tsavaris; Maria Vadiaka; Niki Stavroyianni; Angelos Kou 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Gemcitabine plus epirubicin in patients

Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens

✍ Sergio Ricci; Luca Galli; Aldo Chioni; Mauro Iannopollo; Andrea Antonuzzo; Franc 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract ## BACKGROUND The objective of this study was to evaluate the efficacy and toxicity of gemcitabine plus epirubicin in previously untreated patients with advanced urothelial carcinoma who were not eligible for cisplatin‐based regimens. ## METHODS Patients with advanced urothelial carc

Impact of renal impairment on eligibilit

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder

✍ Atreya Dash; Matthew D. Galsky; Andrew J. Vickers; Angel M. Serio; Theresa M. Ko 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Renal safety and efficacy of cisplatin-b

Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract

✍ Kang Su Cho; Jae Young Joung; Ho Kyung Seo; In-Chang Cho; Han Soo Chung; Jinsoo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 161 KB